1% of global R&D investments are for NTDs

Quotes:
“Estimates of the global total of health R&D investments have been reported at intervals from 1986 (US$30 billion invested, of which $1·6 billion was devoted to the health problems in low-income and middle-income countries) through to 2005 ($160 billion invested, including $5 billion in low-income and middle-income countries). However, despite this overall growth in health R&D, our findings show a persistent imbalance between R&D investments and needs-based priorities as measured by all R&D indicators (research inputs, processes, and outputs). R&D investments in neglected disease research account for only 1% of overall health R&D investments; proportions of ongoing clinical trials addressing type II and III diseases are low; and the geographical distributions of health R&D investments, clinical trial research, and health research publications are heavily skewed towards high-income countries.”

Source:

John-Arne Røttingen, Sadie Regmi, Mari Eide, Alison J Young, Roderik F Viergever, Christine Årdal, Javier Guzman, Danny Edwards, Stephen A Matlin, Robert F Terry, Mapping of available health research and development data: what’s there, what’s missing, and what role is there for a global observatory?, The Lancet, Volume 382, Issue 9900, 12–18 October 2013, Pages 1286-1307, ISSN 0140-6736, http://dx.doi.org/10.1016/S0140-6736(13)61046-6.
(http://www.sciencedirect.com/science/article/pii/S0140673613610466

Advertisements

3 comments

  1. […] PROBABLY BETTER TO USE THIS MORE USEFUL QUOTE FROM A NEW STUDY […]

  2. Yohan Guichoud · · Reply

    Here is the last studies on the subject, with the number of studies on TNDs between 2001-2011:
    http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(13)70078-0/fulltext

    Enjoy 😉

  3. I opened many pages of UAEM Evidence at once, and then found myself a bit confused which was which. Below the citation of the article, so people don’t have to click the ScienceDirect link every time to see what the article’s title was again 🙂

    John-Arne Røttingen, Sadie Regmi, Mari Eide, Alison J Young, Roderik F Viergever, Christine Årdal, Javier Guzman, Danny Edwards, Stephen A Matlin, Robert F Terry, Mapping of available health research and development data: what’s there, what’s missing, and what role is there for a global observatory?, The Lancet, Volume 382, Issue 9900, 12–18 October 2013, Pages 1286-1307, ISSN 0140-6736, http://dx.doi.org/10.1016/S0140-6736(13)61046-6.
    (http://www.sciencedirect.com/science/article/pii/S0140673613610466)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s